Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Departure of Directors or Certain

(d)On October25, 2015, the board of directors (the Board) of Valeant Pharmaceuticals International, Inc. (the Company) increased the number of directors of the Board from eleven to twelve and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed G. Mason Morfit as a director of the Board.Mr.Morfits term as director commenced effective October25, 2015and his current term as director will expire at the Companys 2016 annual shareholder meeting or upon his prior death or resignation, retirement or removal from the Board, whichever is earliest.

Mr.Morfit is a Partner and the President of ValueAct Capital. Prior to joining ValueAct Capital in January 2001, Mr.Morfit worked in equity research...


More